Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Li-Chuan Tan, Wen-Jie Yang, Wei-Ping Fu, Ping Su, Jing-Kui Shu & Lu-Ming Dai. (2018) 1H-NMR-based metabolic profiling of healthy individuals and high-resolution CT-classified phenotypes of COPD with treatment of tiotropium bromide. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2985-2997.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta & Mario Cazzola. (2016) Oxidation pathway and exacerbations in COPD: the role of NAC. Expert Review of Respiratory Medicine 10:1, pages 89-97.
Read now
Read now
Articles from other publishers (5)
Xiaopeng Liu, Zhixiong Hu & Haiying Zhou. (2021) N-Acetylcysteine Improves Inflammatory Response in COPD Patients by Regulating Th17/Treg Balance through Hypoxia Inducible Factor-1α Pathway. BioMed Research International 2021, pages 1-7.
Crossref
Crossref
Yohan Bossé & Michael H. Cho. 2020. Precision in Pulmonary, Critical Care, and Sleep Medicine. Precision in Pulmonary, Critical Care, and Sleep Medicine
39
55
.
Hélder Melro, Jorge Gomes, Gabriela Moura & Alda Marques. (2018) Genetic profile and patient-reported outcomes in chronic obstructive pulmonary disease: A systematic review. PLOS ONE 13:6, pages e0198920.
Crossref
Crossref
Emily S Wan. (2018) Examining genetic susceptibility in acute exacerbations of COPD. Thorax 73:6, pages 507-509.
Crossref
Crossref
Almira Akparova, Balkiya Abdrakhmanova, Nilanjana Banerjee & Rakhmetkazhy Bersimbaev. (2017) EPHX1 Y113H polymorphism is associated with increased risk of chronic obstructive pulmonary disease in Kazakhstan population. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 816-817, pages 1-6.
Crossref
Crossref